Public, NASDAQ:UTHR
NASDAQ Global Select Market
United Therapeutics to Fight Patent Infringement
Date: Mon, 06 Feb 2012 13:29:50 GMT
Tags:
United Therapeutics to Fight Patent Infringement
Metro Business Media - 3 hours ago
Metro Business Media - 3 hours ago
United Therapeutics Corporation (NASDAQ: UTHR)said it received notice from a generic drug manufacturer that it intends to release a remanufactured form of one of Silver Spring-based company's core drugs called Remodulin.
United Therapeutics Receives Paragraph IV Notice Letter for Remodulin - PR Newswire (press release)United Therapeutics Receives Paragraph IV Notice Letter for Remodulin
Date: Mon, 06 Feb 2012 12:06:29 GMT
Tags:
United Therapeutics Receives Paragraph IV Notice Letter for Remodulin
DigitalJournal.com (press release) - 4 hours ago
DigitalJournal.com (press release) - 4 hours ago
SILVER SPRING, Md., Feb. 6, 2012 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012 from Sandoz Inc. (Sandoz) advising that Sandoz has submitted an ...
Top 10 Fastest-Growing Mid Cap Stocks: LNKD, YOKU, TXT, WRI, SM, QCOR, DLPH ...
Date: Fri, 27 Jan 2012 14:34:33 GMT
Tags:
Top 10 Fastest-Growing Mid Cap Stocks: LNKD, YOKU, TXT, WRI, SM, QCOR, DLPH ...
China Analyst - Jan 27, 2012
China Analyst - Jan 27, 2012
Below are the top 10 fastest-growing Mid Cap stocks, based on the average long-term earnings growth rate estimated by Wall Street analysts.
Top 10 Fastest-Growing NASDAQ Stocks: MMYT, RENT, BONA, BIDU, RLOC, QCOR, CTCT ...
Date: Sun, 15 Jan 2012 14:15:39 GMT
Tags:
Top 10 Fastest-Growing NASDAQ Stocks: MMYT, RENT, BONA, BIDU, RLOC, QCOR, CTCT ...
China Analyst - Jan 15, 2012
China Analyst - Jan 15, 2012
Below are the top 10 fastest-growing stocks in the NASDAQ Composite index, based on the average long-term earnings growth rate estimated by Wall Street analysts.
United Therapeutics Corporation's Intravenous Remodulin Approved For Treatment Of Pulmonary Arterial Hypertension
Date: Tue, 27 Dec 2011 12:00:00 GMT
Tags:
United Therapeutics Corporation's Intravenous Remodulin Approved For Treatment Of Pulmonary Arterial Hypertension
Reuters Key Development - Dec 27, 2011
Reuters Key Development - Dec 27, 2011
United Therapeutics to fight generic copy of lead drug
Date: Mon, 06 Feb 2012 13:43:17 GMT
Tags:
UNITED THERAPEUTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
Date: Mon, 06 Feb 2012 12:01:40 GMT
Tags:
United Therapeutics Receives Paragraph IV Notice Letter for Remodulin
Date: Mon, 06 Feb 2012 12:00:00 GMT
Tags:
[PR Newswire] - SILVER SPRING, Md., Feb. 6, 2012 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR - News) today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012 from Sandoz Inc. ...
15 Healthcare Stocks Insiders Bought Recently
Date: Fri, 27 Jan 2012 17:55:56 GMT
Tags:
United Therapeutics Drops on Generic Drug: Washington Mover
Date: Tue, 24 Jan 2012 19:51:07 GMT
Tags: